Aspire Biopharma Holdings (ASBP) Amortizatization of Intangibles (2025 - 2026)

Aspire Biopharma Holdings' (ASBP) quarterly Amortizatization of Intangibles came in at $1.6 million in Q1 2026, up 13530.72% year-on-year from N/an in Q1 2025, and down 73.59% on a QoQ basis from $6.0 million in Q4 2025.

Aspire Biopharma Holdings (ASBP) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Aspire Biopharma Holdings (ASBP) has 2 years of Amortizatization of Intangibles data on file, last reported at $1.6 million in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 13530.72% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.0 million, up 5667.23% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $1.6 million, down from $6.0 million in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for ASBP reached as high as $6.0 million in Q4 2025 and fell as low as $11620.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Aspire Biopharma Holdings 1.09 Mn -733,865.14 5,750.00 1.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.58 Mn
Mar 31, 2026 1.58 Mn
Dec 31, 2025 6.00 Mn
Dec 31, 2025 6.00 Mn
Sep 30, 2025 19,476.00
Sep 30, 2025 19,476.00
Mar 31, 2025 11,620.00
Mar 31, 2025 11,620.00